A Fab-Selective Immunoglobulin-Binding Domain from Streptococcal Protein G with Improved Half-Life Extension Properties.
Half-life extension strategies have gained increasing interest to improve the pharmacokinetic and pharmacodynamic properties of protein therapeutics. Recently, we established an immunoglobulin-binding domain (IgBD) from streptococcal protein G (SpGC3) as module for half-life extension. SpGC3 is capa...
Main Authors: | Felix Unverdorben, Meike Hutt, Oliver Seifert, Roland E Kontermann |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4592230?pdf=render |
Similar Items
-
GlycoTAIL and FlexiTAIL as Half-Life Extension Modules for Recombinant Antibody Fragments
by: Oliver Seifert, et al.
Published: (2022-05-01) -
The Fab portion of immunoglobulin G has sites in the CL domain that interact with Fc gamma receptor IIIa
by: Yuki Yamaguchi, et al.
Published: (2022-12-01) -
Serum immunoglobulin or albumin binding single-domain antibodies that enable tailored half-life extension of biologics in multiple animal species
by: Michiel M. Harmsen, et al.
Published: (2024-01-01) -
Pharmacokinetic Engineering of OX40-Blocking Anticalin Proteins Using Monomeric Plasma Half-Life Extension Domains
by: Martin Siegemund, et al.
Published: (2021-10-01) -
Extension of human GCSF serum half-life by the fusion of albumin binding domain
by: Fatemeh Yadavar Nikravesh, et al.
Published: (2022-01-01)